Dodel R - Search Results

1

Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.

Dodel R, Jönsson B, Reese JP, Winter Y, Martinez-Martin P, Holloway R, Sampaio C, Růžička E, Hawthorne G, Oertel W, Poewe W, Stebbins G, Rascol O, Goetz CG, Schrag A. Dodel R, et al. Mov Disord. 2014 Feb;29(2):169-76. doi: 10.1002/mds.25571. Epub 2013 Jul 16. Mov Disord. 2014. PMID: 23861335 Review.

2

International guide to drugs for Parkinson's disease.

Oertel WH, Dodel RC. Oertel WH, et al. Among authors: dodel rc. Mov Disord. 1995 Mar;10(2):121-31. doi: 10.1002/mds.870100202. Mov Disord. 1995. PMID: 7753054

3

[Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy].

Dodel RC, Pepperl S, Köhne-Volland R, Szucs T, Werhahn KJ, Noachtar S, Oertel WH. Dodel RC, et al. Med Klin (Munich). 1996 Jul 15;91(7):479-85. Med Klin (Munich). 1996. PMID: 8756119 Review. German.

4

Activation mapping in essential tremor with functional magnetic resonance imaging.

Bucher SF, Seelos KC, Dodel RC, Reiser M, Oertel WH. Bucher SF, et al. Among authors: dodel rc. Ann Neurol. 1997 Jan;41(1):32-40. doi: 10.1002/ana.410410108. Ann Neurol. 1997. PMID: 9005863

5

[Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs].

Dodel RC, Singer M, Köhne-Volland R, Selzer R, Scholz W, Rathay B, Oertel WH. Dodel RC, et al. Nervenarzt. 1997 Dec;68(12):978-84. doi: 10.1007/s001150050226. Nervenarzt. 1997. PMID: 9465341 German.

6

Costs of drug treatment in Parkinson's disease.

Dodel RC, Eggert KM, Singer MS, Eichhorn TE, Pogarell O, Oertel WH. Dodel RC, et al. Mov Disord. 1998 Mar;13(2):249-54. doi: 10.1002/mds.870130209. Mov Disord. 1998. PMID: 9539337

7

The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Dodel RC, Singer M, Köhne-Volland R, Szucs T, Rathay B, Scholz E, Oertel WH. Dodel RC, et al. Pharmacoeconomics. 1998 Sep;14(3):299-312. doi: 10.2165/00019053-199814030-00006. Pharmacoeconomics. 1998. PMID: 10186468

8

A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson's disease.

Dodel RC, Lohmüller F, Du Y, Eastwood B, Gocke P, Oertel WH, Gasser T. Dodel RC, et al. Neurology. 2001 Apr 10;56(7):982-3. doi: 10.1212/wnl.56.7.982. Neurology. 2001. PMID: 11294947 No abstract available.

9

Dodel RC, Berger K, Oertel WH. Dodel RC, et al. Pharmacoeconomics. 2001;19(10):1013-38. doi: 10.2165/00019053-200119100-00004. Pharmacoeconomics. 2001. PMID: 11735671 Review.

10

A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD.

Dodel RC, Du Y, Depboylu C, Kurz A, Eastwood B, Farlow M, Oertel WH, Müller U, Riemenschneider M. Dodel RC, et al. Neurology. 2002 Feb 26;58(4):664. doi: 10.1212/wnl.58.4.664. Neurology. 2002. PMID: 11865157 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters